Date | Time | Source | Headline | Symbol | Company |
03/29/2019 | 7:25AM | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/29/2019 | 5:09AM | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/27/2019 | 2:04PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/27/2019 | 7:30AM | GlobeNewswire Inc. | Pain Therapeutics Announces Name Change to Cassava Sciences, Inc. | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/25/2019 | 12:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/25/2019 | 7:30AM | GlobeNewswire Inc. | Pain Therapeutics Reports 2018 Financial Results and Corporate Update | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/22/2019 | 3:10PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
03/04/2019 | 1:56PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/14/2019 | 2:04PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/14/2019 | 12:47PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/13/2019 | 3:36PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/11/2019 | 3:48PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/08/2019 | 3:06PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/08/2019 | 12:11PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/07/2019 | 4:13PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/05/2019 | 12:09PM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
02/05/2019 | 7:00AM | GlobeNewswire Inc. | Pain Therapeutics Announces Feedback from Recent Meeting with FDA on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
01/31/2019 | 5:02AM | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
01/17/2019 | 8:00AM | GlobeNewswire Inc. | Pain Therapeutics Announces Academic Collaboration with The University of Texas at Austin | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
01/16/2019 | 8:00AM | GlobeNewswire Inc. | Pain Therapeutics Awarded $1.5 Million Research Grant by National Institutes of Health | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
01/07/2019 | 7:30AM | GlobeNewswire Inc. | Pain Therapeutics Announces Two New Peer-Reviewed Publications for REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
12/18/2018 | 5:00PM | GlobeNewswire Inc. | Pain Therapeutics Announces Filing of Registration Statement on SEC Form S-1 | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
12/18/2018 | 4:29PM | Edgar (US Regulatory) | Securities Registration Statement (s-1) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
12/10/2018 | 2:46PM | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
12/06/2018 | 6:30AM | GlobeNewswire Inc. | Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
11/12/2018 | 6:30AM | GlobeNewswire Inc. | Pain Therapeutics Appeals FDA Decision on REMOXY | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
11/01/2018 | 3:34PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
10/31/2018 | 3:04PM | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
10/30/2018 | 3:44PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |
10/29/2018 | 3:09PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:PTIE | Pain Therapeutics, Inc. (MM) |